|
|||||
|
|
Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756) |
|
| Abstract: | Scientific evaluation of a patent aiming for the development of pyrazolopyridine derivatives as LRRK2 kinase inhibitors, a potential therapeutic target for combating Parkinson's disease. |
| Keywords: | LRRK2 kinase inhibitor Parkinson's disease patent evaluation pyrazolopyridine |